Sign in
4

Changes in Ownership

BIODESIX INC Filed Acc 0001140361-22-018732

Chief Development Officer sold 1,467 shares at $1.83 ($2,685)

  • Chief Development Officer acquired 5,054 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pestano Gary Anthony · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-09 Exercise or conversion : show line 1 in the form +5,054 87,220 D
2022-05-10 Sale : show line 2 in the form −1,467 $1.83 $2,685 85,753 D
Open-market sales · 1,467 sh · avg $1.83 · $2,685

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2022-05-09 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,378 1,378 20,674 D
2022-05-09 Exercise or conversion : show line 4 in the form Restricted Stock Units −3,676 3,676 18,377 D
Loading xslF345X03/form4.xml…